Literature DB >> 12389025

Bimodal cardiac dysfunction in an animal model of iron overload.

Tianen Yang1, Wei-Qiang Dong, Yuri A Kuryshev, Carlos Obejero-Paz, Matthew N Levy, Gary M Brittenham, Songsak Kiatchoosakun, Darryl Kirkpatrick, Brian D Hoit, Arthur M Brown.   

Abstract

Iron-overload cardiomyopathy is the most common cause of death in patients with thalassemia major, yet the associated changes in cardiac function have not been quantified. We studied the effects of iron overload on cardiac function in Mongolian gerbils, a species that responds to iron overload in the same manner as human beings. We injected iron-dextran or dextran alone at low subcutaneous doses (200 mg/kg/wk) for 20 to 60 weeks and at high doses (800 mg/kg/wk) for 6 to 20 weeks. At shorter durations for either dose, the mean values of cardiac work, coronary flow, left ventricular (dP/dt)(max) and left ventricular (dP/dt)(min) in isolated perfused hearts were significantly greater than control values; at longer durations, these values were significantly less than control values. Echocardiography in intact animals showed eccentric cardiac hypertrophy, increased cardiac output, and normal exercise tolerance at shorter durations of dosage. At longer durations, concentric cardiac hypertrophy developed, and cardiac output and exercise capacity were impaired. The response to iron overload in Mongolian gerbils progresses from an initial state of high cardiac output to a subsequent state of low-output failure similar to the course of cardiomyopathy that has been inferred in patients with transfusional iron overload.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12389025     DOI: 10.1067/mlc.2002.127725

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Combined histological and hematological assessment of iron-induced organ damage in a gerbil model of iron overload.

Authors:  Man Wang; Rong-Rong Liu; Cong-Jun Wang; Wei Kang; Gao-Hui Yang; Wu-Ning Zhong; Yong-Rong Lai
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

2.  Calcium channels and iron uptake into the heart.

Authors:  Nipon Chattipakorn; Sirinart Kumfu; Suthat Fucharoen; Siriporn Chattipakorn
Journal:  World J Cardiol       Date:  2011-07-26

3.  Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil.

Authors:  John C Wood; Maya Otto-Duessel; Ignacio Gonzalez; Michelle I Aguilar; Hiro Shimada; Hanspeter Nick; Marvin Nelson; Rex Moats
Journal:  Transl Res       Date:  2006-11       Impact factor: 7.012

Review 4.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

5.  Ventriculo-vascular interactions in patients with beta thalassaemia major.

Authors:  Y F Cheung; S Y Ha; G C F Chan
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

6.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

7.  Antioxidant-mediated effects in a gerbil model of iron overload.

Authors:  Maya Otto-Duessel; Michelle Aguilar; Rex Moats; John C Wood
Journal:  Acta Haematol       Date:  2007-10-16       Impact factor: 2.195

8.  Effect of iron overload on exercise capacity in thalassemic patients with heart failure.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Dimitrios Verganelakis; Eleni Berdousis; Athanasios Dritsas; Genovefa Kolovou; Panagiotis Toulas; Vassilios Ladis
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-13       Impact factor: 2.357

9.  Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.

Authors:  Amarah Shakoor; Maaman Zahoor; Alina Sadaf; Najveen Alvi; Zehra Fadoo; Arjumand Rizvi; Farheen Quadri; Fateh Ali Tipoo; Mohammad Khurshid; Zaffar Sajjad; Steven Colan; Babar S Hasan
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.